biolitec® in Urology

Minimally invasive laser therapy

LIFE of benign prostatic hyperplasia

Feasable also for risk patients with chronic diseases

Fotolia 45238733 XSProstate diseases, such as benign prostate enlargement, can occur in men with increasing age. If left untreated, these can lead to complaints in everyday life. The feeling of constant urge to urinate, repeated cystitis due to high residual urine quantities in the bladder, up to complete urinary blockages can have an enormous impact on the quality of life of the patient.

In older standard therapies, such as electroresection, impotence and incontinence as well as significant blood loss may occur during and after surgery. There is also a risk of blood loss or bladder injury with certain laser systems. Therefore biolitec® has developed the minimally invasive laser therapy LIFE for the treatment of benign BPH.

Especially for risk groups, such as patients who have to take blood thinners to avoid thrombosis, strokes or after heart valve operations, conventional operations may be problematic. People with congenital coagulation disorders such as haemophilia (haemophilia) or cardiovascular diseases also have an increased risk of undergoing surgery.

With LIFE laser therapy, high-risk patients can also be treated with local anaesthesia. The patient therefore benefits from the gentle anaesthesia procedure, as the cardiovascular system is less strained overall.